• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19?

tetano

Editor, Senior Moderator
Front Immunol


. 2022 Jan 24;12:745713.
doi: 10.3389/fimmu.2021.745713. eCollection 2021.
Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19?


Federica Saponaro[SUP] 1 [/SUP], Maria Franzini[SUP] 2 [/SUP], Chukwuma Okoye[SUP] 3 [/SUP], Rachele Antognoli[SUP] 3 [/SUP], Beatrice Campi[SUP] 1 [/SUP], Marco Scalese[SUP] 4 [/SUP], Tommaso Neri[SUP] 1 [/SUP], Laura Carrozzi[SUP] 1 [/SUP], Fabio Monzani[SUP] 3 [/SUP], Riccardo Zucchi[SUP] 1 [/SUP], Alessandro Celi[SUP] 1 [/SUP], Aldo Paolicchi[SUP] 2 [/SUP], Alessandro Saba[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Hypovitaminosis D has been suggested to play a possible role in coronavirus disease 2019 (COVID-19) infection.
Methods: The aim of this study is to analyze the relationship between vitamin D status and a biochemical panel of inflammatory markers in a cohort of patients with COVID-19. A secondary endpoint was to evaluate the correlation between 25OHD levels and the severity of the disease. Ninety-three consecutive patients with COVID-19-related pneumonia were evaluated from March to May 2020 in two hospital units in Pisa, in whom biochemical inflammatory markers, 25OHD levels, P/F ratio at nadir during hospitalization, and complete clinical data were available.
Results: Sixty-five percent of patients presented hypovitaminosis D (25OHD ≤ 20 ng/ml) and showed significantly higher IL-6 [20.8 (10.9-45.6) vs. 12.9 (8.7-21.1) pg/ml, p = 0.02], CRP [10.7 (4.2-19.2) vs. 5.9 (1.6-8.1) mg/dl, p = 0.003], TNF-α [8.9 (6.0-14.8) vs. 4.4 (1.5-10.6) pg/ml, p = 0.01], D-dimer [0.53 (0.25-0.72) vs. 0.22 (0.17-0.35) mg/l, p = 0.002], and IL-10 [3.7 (1.8-6.9) vs. 2.3 (0.5-5.8) pg/ml, p = 0.03]. A significant inverse correlation was found between 25OHD and all these markers, even adjusted for age and sex. Hypovitaminosis D was prevalent in patients with severe ARDS, compared with the other groups (75% vs. 68% vs. 55%, p < 0.001), and 25OHD levels were lower in non-survivor patients.
Conclusions: The relationship between 25OHD levels and inflammatory markers suggests that vitamin D status needs to be taken into account in the management of these patients. If vitamin D is a marker of poor prognosis or a possible risk factor with beneficial effects from supplementation, this still needs to be elucidated.

Keywords: COVID-19; SARS-CoV-2; cytokine storm; hypovitaminosis D; vitamin D.
 
Back
Top Bottom